Clinical practice guidelines for colorectal cancer screening: New recommendations and new challenges

JAMA - Journal of the American Medical Association

Volumn 315, Issue 23, 2016, Pages 2529-2531

  Ransohoff, David F ^a   Sox, Harold C ^b,c  

^a University of North Carolina at Chapel Hill   (United States)

^b Outcomes Research Institute   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER SCREENING; COLORECTAL CANCER; CONFLICT OF INTEREST; CONSENSUS; DECISION MAKING; HUMAN; LIFE EXPECTANCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCREENING TEST; SIGMOIDOSCOPY; ADVISORY COMMITTEE; AGE; CHEMISTRY; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; IMMUNOHISTOCHEMISTRY; OCCULT BLOOD; PREVENTIVE HEALTH SERVICE; UNITED STATES;

ADVISORY COMMITTEES; AGE FACTORS; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; HUMANS; IMMUNOHISTOCHEMISTRY; OCCULT BLOOD; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 84975704310     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.7990     Document Type: Review

References (11)

1. Woolf SH, Campos-Outcalt D. Severing the link between coverage policy and the US Preventive Services Task Force. JAMA. 2013;309(18):1899-1900.
2. Lin KW, Gostin LO. A public health framework for screening mammography: evidence-based vs politically mandated care. JAMA. 2016;315(10):977-978.
3. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. doi:10.1001/jama.2016.5989.
4. Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016.3332.
5. Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016.6828.
6. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
7. US Preventive Services Task Force. Draft Recommendation Statement: Colorectal Cancer: Screening. http://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement38/colorectal-cancer-screening2. October 2015. Accessed May 31, 2016.
8. Zauber AG, Knudsen AB, Rutter CM, Lansdorp-Vogelaar I, Kuntz KM. Evaluating the benefits and harms of colorectal cancer screening strategies: a collaborative modeling approach. AHRQ Publication 14-05203-EF-2 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/modeling-report/colorectal-cancer-screening2. October 2015. Accessed May 31, 2016.
9. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659-669.
10. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370(14): 1298-1306.
11. Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al. Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: a microsimulation model. JAMA. 2015; 313(23):2349-2358.